News

Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the closing of a common stock financing totaling $10.8...

NanoView Biosciences, a leading biomarker characterization company in the emerging field of extracellular vesicle biology, today announced a collaboration agreement with Beth Israel Deaconess...

The research team led by Prof. KE Yuehai at the Zhejiang University School of Medicine identified a group of tyrosine phosphatases that regulate the...

Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into an agreement with Oklahoma State University to evaluate Zofin™ for the treatment of...

Because cancer is easier to successfully treat when it's caught early, a major goal in cancer research is to develop new ways to find tumors at early stages, before they start to spread. One approach...

Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics...

Researchers from North Carolina State University have developed an exosome-coated stent with a “smart-release” trigger that could both prevent reopened blood vessels from narrowing and deliver regenerative stem cell-derived therapy to blood-starved, or ischemic, tissue. Angioplasty – a procedure that ...

MDimune Inc. and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining MDimune’s...

With well-established phage display technology and a professional scientist team providing real-time guidance, Creative Biolabs has released novel exosome antibody development services....

Sugars make up about 95% of honey, explaining how the substance became synonymous with sweetness and a food staple of bee colonies, which repeatedly digest and regurgitate flower nectar to produce it. But people have also historically used honey as an ...